Typicality: | 0.484 |
Saliency: | 0.345 |
in the united states | 9 | location |
by the fda | 3 | other |
in 1967 | 2 | temporal |
drug → be approved for → clinical use | 27 |
drug → be approved for → new indication | 5 |
drug → be approved for → the indication | 4 |
drug → be approved for → indication | 4 |
negative | neutral | positive |
0.115 | 0.607 | 0.278 |
Raw frequency | 40 |
Normalized frequency | 0.345 |
Modifier score | 0.767 |
Perplexity | 36.620 |